AREA 23 wins Healthcare Agency of the Year and a Grand Prix for “Magnetic Stories”.
After a brief market exit in November 2022, GSK appears to be giving its multiple myeloma treatment Blenrep a second chance, with company executives touting its “multi-blockbuster” potential in a virtual oncology-focused investor event on Monday.
The FDA has slapped a partial clinical hold on BioNTech and MediLink’s Phase I study of an antibody-drug conjugate candidate for types of non-small cell lung cancer or breast cancer, following multiple patient deaths.
Read on to find out the shortlists and winners thus far.
The 20+ year industry veteran joins the team as executive VP, consulting.
Novo Nordisk CEO Lars Jørgensen has agreed to testify before the Senate Health, Education, Labor and Pensions Committee regarding the prices of the pharma’s top-selling semaglutide brands Ozempic and Wegovy, according to Sen. Bernie Sanders (I-Vt.).